Bluebook
Pharma Services November 2020
2020 - November: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- IntegReview IRB was acquired by Advarra
- Shanghai Youlin Pharmaceutical Technology closed a $14.9mm round of funding, led by Cenova Ventures
- Outcomes4me closed a $4.7mm round of funding, led by Asset Management Ventures